Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K33/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2023/001814COMPOSITION FOR USE IN THE PREVENTION OF SEVERE FORMS OF VIRAL INFECTIONS DUE TO BETACORONAVIRUS
WO 26.01.2023
Int.Class A61K 31/155
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
155Amidines , e.g. guanidine , isourea , isothiourea
Appl.No PCT/EP2022/070184 Applicant CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES Inventor CORBEAU, Pierre
The present invention concerns a composition comprising an Angiotensin receptor 1 (AT1) inhibitor and one or more other active compounds selected from the group consisting of antioxidants, caspase inhibitors, and mixtures thereof, for use as a drug in subjects in need thereof, for preventing and/or treating viral infections due to at least one betacoronavirus, in particular for preventing severe forms of viral infections due to betacoronavirus, in particular COVID-19 due to SARS-CoV-2.
2.WO/2023/004101CALCIUM GLUCONATE FORMULATION WITHOUT CALCIUM SACCHARATE
WO 26.01.2023
Int.Class A61K 31/7012
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
Appl.No PCT/US2022/037990 Applicant NIVAGEN PHARMACEUTICALS, INC. Inventor MANGALI, Thuripathi
Described is an aqueous calcium gluconate solution formulated without calcium saccharate, which can be stored in a flexible plastic bag and can be terminally sterilized.
3.WO/2023/003052COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING ANTICANCER DRUG-RESISTANT OVARIAN CANCER, CONTAINING ARL6IP5 PROTEIN AS ACTIVE INGREDIENT
WO 26.01.2023
Int.Class A61K 38/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
Appl.No PCT/KR2021/009406 Applicant INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY Inventor YOON, Hyon Ok
The present invention relates to a composition for preventing, alleviating or treating anticancer drug-resistant ovarian cancer, containing an ARL6IP5 protein as an active ingredient, wherein the ARL6IP5 protein of the present invention has the excellent effects of increasing apoptosis of ovarian cancer cells resistant to cisplatin and inhibiting the cell proliferation thereof, and also significantly enhances anticancer effects when used together with cisplatin or olaparib, and thus can be very effectively used in the development of medicines or health functional foods for preventing, alleviating or treating cisplatin-resistant ovarian cancer.
4.202022106634Ein System zur Entwicklung von pflanzlichen Nanopartikeln mit antibakterieller, antibiofilmischer, wundheilender und krebshemmender Wirkung
DE 26.01.2023
Int.Class A61K 36/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
Appl.No 202022106634 Applicant Annamalai University Inventor

System zur Entwicklung von pflanzlichen Nanopartikeln mit antibakterieller, antibiofilmischer, heilender und krebshemmender Wirkung, wobei das System umfasst: eine Aufbereitungseinheit zur Aufbereitung von Pflanzenmaterial für die Synthese von Nanopartikeln, wobei frische Blätter der Pflanze Alternanthera sessilis gesammelt werden und ein wässriger Extrakt dieser Pflanze hergestellt wird; eine Syntheseeinheit zur Herstellung von Silbernanopartikeln, in der etwa 10 % des Pflanzenextrakts mit 1 mM Silbernitratlösung in einem Verhältnis von 2:1 unter ständigem Rühren über einen Zeitraum von 2 bis 3 Stunden verschmolzen werden und anschließend Pulver aus der resultierenden Mischung hergestellt wird; und eine Charakterisierungseinheit zur Charakterisierung der synthetisierten Silber-Nanopartikel, wobei die Silber-Nanopartikel durch Anwendung verschiedener Charakterisierungstechniken charakterisiert werden. embedded image

5.WO/2023/003908TREATMENT OF EXPOSURE TO VESICANTS
WO 26.01.2023
Int.Class A61K 9/51
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules
51Nanocapsules
Appl.No PCT/US2022/037634 Applicant BOSTON, Judith Inventor BOSTON, Judith
This disclosure relates to the use of an oxygen-containing liquid as a counter measure against vesicants.
6.4122472AQUEOUS COMPOSITION USED IN THE TREATMENT OF DIGESTIVE DISORDERS IN ANIMALS
EP 25.01.2023
Int.Class A61K 33/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
04Sulfur, selenium or tellurium; Compounds thereof
Appl.No 22185685 Applicant DOMES PHARMA Inventor CHAUDER ANNE
La présente invention concerne une composition comprenant, par rapport au poids total de la composition :- de 20% à 60% en poids de charbon actif,- de 4% à 13% en poids de sulfate de sodium,- de 10% à 34% en poids de glycérine,- de 0,15% à 1,25% en poids de gomme de xanthane,- de 25% à 70% en poids d'eau.La composition est utilisée notamment pour le traitement des troubles digestifs chez l'animal, et tout particulièrement pour le traitement des intoxications par voie orale.
7.202200125Natural dermal cream for sensitive, eczematous and dermatosis skin
SK 25.01.2023
Int.Class A61K 36/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
Appl.No 2022000125 Applicant NAMY s. r. o. Inventor JezikMartin
Natural dermal cream for sensitive, eczematous and dermatosis skin composed of a homogeneous mixture of 15 to 65% by weight of water, 15 to 65% by weight of plant hydrolate, 0.01 to 30% by weight of vegetable oil, 0.01 to 30% by weight of macerate of a medicinal plant in vegetable oil, 1 to 30% by weight of zinc oxide or titanium dioxide, 1 to 30% by weight of vegetable emulsifier, 0.01 to 10% by weight of vegetable glycerine, 0.01 to 3% by weight of sodium salt of levulic acid, 0.01 to 2% by weight of sodium salt of anisic acid, 0.01 to 10% by weight of stearic acid, 0.01 to 5% by weight of essential oil, 0.01 to 3% by weight of vitamin E, 0.01 to 2% by weight of bisabolol and 0.01 to 2% by weight of natural preservative.
8.4122459COMPOSITION FOR PREVENTING AND TREATING NAIL ALTERATIONS AND DISEASES
EP 25.01.2023
Int.Class A61K 31/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
Appl.No 22186396 Applicant GIULIANI SPA Inventor GIULIANI GIAMMARIA
The present invention concerns a composition for preventing and treating nail alterations and diseases comprising spilanthol, or a Spilanthes acmella extract which contains it, in combination with zinc and cocoa. The composition is formulated for topical or oral application. The composition accelerates the repair process of the structural alterations of the nail plate regardless of the traumatic, infectious, or nutritional origin.
9.4122456COMPOSITION FOR USE IN THE TREATMENT OF COMMON COLD, PREPARATION METHOD AND USE THEREOF
EP 25.01.2023
Int.Class A61K 31/045
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
Appl.No 22180872 Applicant WEBER CHUCKIE Inventor WEBER CHUCKIE
The invention relates to a medicinal composition for treating a cold, a preparation method and application thereof. The cold medication composition is made from aloe vera soap, an isopropyl alcohol solution, sea salt, distilled water, and natural gum resin. The invention also relates to a preparation method of the composition and the application of the composition for treating the cold.
10.11559053Livestock footbath solutions and methods of use
US 24.01.2023
Int.Class A01L 15/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
LSHOEING OF ANIMALS
15Apparatus or use of substances for the care of hoofs
Appl.No 15713534 Applicant Specialty Sales, LLC Inventor Greg Petersen

Embodiments of the present invention provide improved livestock foot bath solutions that are capable of maintaining a low pH during longer periods of use in order to help prevent the metal salts from precipitating out of the solution and rendering the solution ineffective. Embodiments of the present invention provide improved livestock foot bath solutions that include one or more weak organic acids, such as polyprotic organic acids, in the aqueous solution, along with the dissolved metal salts. Embodiments of the invention may also include sulfuric acid, or some other strong acid, together with citric acid and the dissolved metal salts in the aqueous solution.